Copyright
©2012 Baishideng Publishing Group Co.
World J Gastroenterol. May 7, 2012; 18(17): 2035-2042
Published online May 7, 2012. doi: 10.3748/wjg.v18.i17.2035
Published online May 7, 2012. doi: 10.3748/wjg.v18.i17.2035
Figure 5 Transcriptional regulation of STMN (stathmin) by transforming growth factor-β-inducible early gene 1.
A and B: Decreases in mRNA and protein levels of STMN in Bel7404 and HepG2 cells transfected by lenti-transforming growth factor-β-inducible early gene 1 (TIEG1), revealed by reverse transcriptase-polymerase chain reaction and Western blotting analyzes; C: Dose-dependent suppression of STMN promoter activity by TIEG1 monitored by a luciferase reporter gene system. Control: pEGFP-N1.
- Citation: Jiang L, Lai YK, Zhang JF, Chan CY, Lu G, Lin MC, He ML, Li JC, Kung HF. Transactivation of the TIEG1 confers growth inhibition of transforming growth factor-β-susceptible hepatocellular carcinoma cells. World J Gastroenterol 2012; 18(17): 2035-2042
- URL: https://www.wjgnet.com/1007-9327/full/v18/i17/2035.htm
- DOI: https://dx.doi.org/10.3748/wjg.v18.i17.2035